Oxzesys 300 Tablet contains Oxcarbazepine 300mg, an anticonvulsant medication primarily indicated for the treatment of epilepsy. It is effective in managing partial seizures with or without secondary generalization in adults and children aged four years and above. Oxcarbazepine acts by stabilizing hyperexcited neural membranes, inhibiting repetitive neuronal firing, and reducing synaptic impulse propagation through modulation of voltage-sensitive sodium channels. This action helps to prevent seizure activity and maintain seizure control. Oxzesys 300 Tablet is typically administered orally, with dosage individualized based on patient response and tolerability. Common adverse effects may include dizziness, somnolence, headache, nausea, and hyponatremia, necessitating periodic monitoring of serum sodium levels during therapy. Caution is advised in patients with a history of hypersensitivity to carbamazepine or related compounds, as cross-reactivity may occur. Oxzesys should be used under strict medical supervision, particularly in populations such as pregnant or lactating women, where risk-benefit assessment is crucial. Concomitant use with other antiepileptic drugs may require dose adjustments to optimize therapeutic outcomes. Patients are advised to adhere to prescribed dosing schedules and report any adverse reactions or signs of allergic response promptly to their healthcare provider.